Product Information
FENOFIBRATE 130 MG CAPSULE is a generic product labeled by Apotex Corp., priced at $0.6544 per EA under NDC 60505312103. Its NADAC has been published 657 times since Nov 28, 2013.
Strength
130 mg/1
Manufacturer
Apotex Corp.NDC
60505312103
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
FENOFIBRATEApproval Type
Generic (ANDA)
FDA Application
ANDA202252On Market Since
7/26/2013
Pharmacological Classes
Price Statistics
The NADAC for FENOFIBRATE 130 MG CAPSULE has been published 657 times since Nov 28, 2013, and over the history we have for it it has declined 87.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6544 per EA |
|---|---|
| All-time high | $5.1386 (Feb 12, 2014) |
| All-time low | $0.5104 (Sep 20, 2023) |
| 52-week high | $0.8173 |
| 52-week low | $0.6544 |
| Median price | $1.8496 |
| Average price | $2.2273 |
| Largest weekly change | -52.7% (Aug 23, 2023) |
| Weeks tracked | 657 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of FENOFIBRATE 130 MG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for FENOFIBRATE 130 MG CAPSULE, manufactured by Apotex Corp., is $0.6544 per EA (NDC 60505312103), effective Jun 24, 2026.
How has the price of FENOFIBRATE 130 MG CAPSULE changed over time?
Over the history we have for it, the NADAC for FENOFIBRATE 130 MG CAPSULE has declined 87.2%. It has been tracked across 657 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for FENOFIBRATE 130 MG CAPSULE?
Since Nov 28, 2013, the NADAC for FENOFIBRATE 130 MG CAPSULE has ranged from a low of $0.5104 (Sep 20, 2023) to a high of $5.1386 (Feb 12, 2014), with a median of $1.8496 per EA.
Are there cheaper alternatives to FENOFIBRATE 130 MG CAPSULE?
3 NADAC-published products share the same active ingredient, strength, and dosage form as FENOFIBRATE 130 MG CAPSULE, but none are currently priced below it.
Who manufactures FENOFIBRATE 130 MG CAPSULE?
FENOFIBRATE 130 MG CAPSULE (NDC 60505312103) is labeled by Apotex Corp., and CMS classifies it as a generic product.
Related Drugs
Same classification